Document Detail


PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation.
MedLine Citation:
PMID:  22766505     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neuroblastoma, the most common extra-cranial solid tumor in infants and children, is characterized by a high rate of spontaneous remissions in infancy. Retinoic acid (RA) has been known to induce neuroblastoma differentiation; however, the molecular mechanisms and signaling pathways that are responsible for RA-mediated neuroblastoma cell differentiation remain unclear. Here, we sought to determine the cell signaling processes involved in RA-induced cellular differentiation. Upon RA administration, human neuroblastoma cell lines, SK-N-SH and BE(2)-C, demonstrated neurite extensions, which is an indicator of neuronal cell differentiation. Moreover, cell cycle arrest occurred in G1/G0 phase. The protein levels of cyclin-dependent kinase inhibitors, p21 and p27(Kip), which inhibit cell proliferation by blocking cell cycle progression at G1/S phase, increased after RA treatment. Interestingly, RA promoted cell survival during the differentiation process, hence suggesting a potential mechanism for neuroblastoma resistance to RA therapy. Importantly, we found that the PI3K/AKT pathway is required for RA-induced neuroblastoma cell differentiation. Our results elucidated the molecular mechanism of RA-induced neuroblastoma cellular differentiation, which may be important for developing novel therapeutic strategy against poorly differentiated neuroblastoma.
Authors:
Jingbo Qiao; Pritha Paul; Sora Lee; Lan Qiao; Erlena Josifi; Joshua R Tiao; Dai H Chung
Related Documents :
15128665 - Cell cycling through development.
22387805 - Polycyclic aromatic hydrocarbons suppress meiosis in primordial germ cells via the ahr ...
2016745 - A general approach to the isolation of cell cycle-regulated genes in the budding yeast,...
20877475 - A key commitment step in erythropoiesis is synchronized with the cell cycle clock throu...
9581765 - Brain control of embryonic circadian rhythms in the silkmoth antheraea pernyi.
18362515 - Autophagy: an emerging target for cancer therapy.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-07-02
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  424     ISSN:  1090-2104     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-06     Completed Date:  2012-11-19     Revised Date:  2013-08-13    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  421-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Differentiation
Extracellular Signal-Regulated MAP Kinases / metabolism*
G0 Phase
G1 Phase Cell Cycle Checkpoints
Humans
Neuroblastoma / enzymology*,  pathology
Phosphatidylinositol 3-Kinases / metabolism*
Phosphorylation
Proto-Oncogene Proteins c-akt / metabolism*
Tretinoin / pharmacology*
Grant Support
ID/Acronym/Agency:
R01 DK061470/DK/NIDDK NIH HHS; R01 DK61470/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
302-79-4/Tretinoin; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells.
Next Document:  Transcriptional activity of paired homeobox Pax6 is enhanced by histone acetyltransferase Tip60 duri...